MARRONE BIO INNOVATIONS INC MBII Income Statement

Marrone bio innovations inc (MBII)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Sep'12	Jun'12
Revenues:
Total revenues
30,307	29,373	28,398	26,857	25,612	21,220	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product
-	-	-	-	-	-	-	-	-	-	-	-	15,234	13,715	12,899	11,645	9,779	8,976	8,098	7,684	7,470	7,750	8,927	8,635	7,553	7,588	6,135	5,967	0	0	0
License
-	-	-	-	-	-	-	-	-	-	-	-	293	327	353	351	342	333	320	302	270	232	210	193	190	193	220	260	0	0	0
Related party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	492	568	725	748	1,154	1,175	1,217	1,216	665	0	0	0	-	-
Total revenues
-	-	-	-	-	-	-	-	-	-	17,539	16,954	15,527	14,042	13,265	12,106	10,414	9,801	8,986	8,711	8,488	9,136	10,312	10,045	8,959	8,446	6,910	6,486	0	0	0
Cost of product revenues
13,612	13,260	13,130	12,552	12,394	10,907	9,866	9,555	10,491	10,528	10,379	10,380	9,532	9,522	9,804	9,651	9,527	9,256	8,764	9,926	9,643	9,438	10,656	8,748	7,622	7,243	5,114	4,204	0	0	0
Gross profit
16,695	16,113	15,268	14,305	13,218	10,313	8,953	8,058	7,846	7,639	7,160	6,574	5,995	4,520	3,461	2,455	887	545	222	-1,215	-1,155	-302	-344	1,297	1,337	1,203	1,796	2,282	0	0	0
Operating Expenses:
Research, development and patent
14,318	14,026	13,312	12,210	11,069	10,662	10,057	10,551	10,911	10,820	10,822	10,332	9,792	9,670	10,605	11,385	12,400	13,500	16,095	17,470	18,406	19,281	19,605	19,242	18,919	17,905	0	0	0	-	-
Research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Selling, general and administrative
32,391	30,072	27,094	21,657	19,799	19,155	18,161	19,174	19,501	19,814	20,304	18,884	18,323	18,510	19,683	21,246	24,145	26,502	29,927	32,004	30,513	28,950	24,164	21,297	18,494	15,017	13,108	10,747	0	0	0
Total operating expenses
46,709	44,098	40,406	33,867	30,868	29,817	28,218	29,725	30,412	30,634	31,126	29,216	28,115	28,180	30,288	32,631	36,545	40,002	46,022	49,474	48,919	48,231	43,769	40,539	37,413	32,922	28,136	23,736	0	0	0
Loss from operations
-30,014	-27,985	-25,138	-19,562	-17,650	-19,504	-19,265	-21,667	-22,566	-22,995	-23,966	-22,642	-22,120	-23,660	-26,827	-30,176	-35,658	-39,457	-45,800	-50,689	-50,074	-48,533	-44,113	-39,242	-36,076	-31,719	-26,340	-21,454	0	0	0
Other (expense) income:
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	37	55	61	57	51	46	53	58	59	66	69	58	49	35	15	0	0	0
Interest expense
1,505	1,474	1,312	1,257	1,244	2,057	2,824	3,328	3,857	3,374	2,699	2,650	2,540	2,941	3,300	3,232	3,132	2,764	2,684	2,766	2,970	2,907	2,953	3,306	4,694	6,056	5,934	5,413	0	0	0
Interest expense, related parties
-	-	-	-	-	451	1,549	2,647	3,715	4,355	4,640	4,641	4,639	4,361	3,479	0	0	-	0	-	-	-	0	-	-	-	-	-	-	-	-
Change in fair value of financial instruments
-	-	-	-	-	-5,177	-5,273	-5,273	-5,273	-96	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-6,717	756	4,051	0	0	0
Loss on extinguishment of debt, net
-	-	-	-	-	-2,196	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Gain on extinguishment of debt, related party
-	-	-	-	-	9,183	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on modification of warrants
-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on issuance of new warrants
0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent consideration
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income, net
396	255	127	64	38	-11	-67	-110	-129	-105	-53	-105	-147	-146	-143	-63	38	41	8	-130	-272	-278	-447	-375	-284	-282	-77	-4	0	0	0
Total other (expense) income, net
-10,234	-9,190	-7,500	-1,193	-1,223	-709	-2,726	-4,371	-5,987	-7,930	-7,388	-7,384	-7,304	-7,411	-7,464	-6,712	-5,432	-4,271	-3,131	-2,843	-3,184	-3,126	-3,334	118	5,409	477	-6,683	-9,404	0	0	0
Loss before taxes
0	-	-	-	0	-	-	-	-	-	-	-	-	-31,071	-34,291	-36,888	-41,090	-43,728	-48,931	-53,532	-53,258	-51,659	-47,447	-39,124	-30,667	-31,242	0	0	0	-	-
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Income tax expense
0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Net loss
-40,282	-37,175	-32,638	-20,755	-18,873	-20,213	-21,991	-26,038	-28,553	-30,925	-31,354	-30,026	-29,424	-31,071	-34,291	-36,888	-41,090	-43,728	-48,931	-53,532	-53,258	-51,659	-47,447	-39,124	-30,667	-31,242	0	0	0	-	0
Basic and diluted net loss per common share:
-0.05	-0.08	-0.14	-0.06	-0.04	-0.05	-0.04	-0.04	-0.07	-0.23	-0.27	-0.25	-0.31	-0.31	-0.29	-0.28	-0.38	-0.45	-0.40	-0.45	-0.49	-	-0.59	-	-	-	-	-	-	-	-3.13
Weighted-average shares outstanding used in computing basic and diluted net loss per common share:
141,572	134,328	116,186	110,723	110,691	111,186	110,568	108,647	74,591	56,163	31,351	29,401	24	24,841	24,460	24,598	24,569	24,481	24,465	24,465	24,465	-	24,421	-	-	-	-	-	-	-	1,251
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0
Deemed dividend on convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.66	-	-0.52	-0.53	-0.63	-0.47	-2.84	-8.59	-10.94	-
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.66	-	-0.52	-0.53	-0.63	-0.80	-3.12	-8.59	-10.94	-
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24,464	-	20,775	19,518	19,246	12,888	1,277	1,268	1,262	-
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	24,464	-	20,775	19,518	19,246	13,422	1,347	1,268	1,262	-
Product [Member]
Total revenues
29,846	28,912	27,946	26,397	25,152	20,775	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License [Member]
Total revenues
461	461	452	460	460	445	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-